Bio-Techne Corp Financials
| TE1 Stock | 71.50 2.50 3.62% |
Bio-Techne |
Please note, the imprecision that can be found in Bio-Techne Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bio Techne Corp. Check Bio-Techne Corp's Beneish M Score to see the likelihood of Bio-Techne Corp's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | US09073M1045 |
| Benchmark | Dow Jones Industrial |
You should never invest in Bio-Techne Corp without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bio-Techne Stock, because this is throwing your money away. Analyzing the key information contained in Bio-Techne Corp's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bio-Techne Corp Key Financial Ratios
Bio-Techne Corp's financial ratios allow both analysts and investors to convert raw data from Bio-Techne Corp's financial statements into concise, actionable information that can be used to evaluate the performance of Bio-Techne Corp over time and compare it to other companies across industries.Bio-Techne Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio-Techne Corp's current stock value. Our valuation model uses many indicators to compare Bio-Techne Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio-Techne Corp competition to find correlations between indicators driving Bio-Techne Corp's intrinsic value. More Info.Bio Techne Corp is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Bio Techne Corp is about 1,727,870,166 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio-Techne Corp's earnings, one of the primary drivers of an investment's value.Bio Techne Corp Systematic Risk
Bio-Techne Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bio-Techne Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Bio Techne Corp correlated with the market. If Beta is less than 0 Bio-Techne Corp generally moves in the opposite direction as compared to the market. If Bio-Techne Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bio Techne Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bio-Techne Corp is generally in the same direction as the market. If Beta > 1 Bio-Techne Corp moves generally in the same direction as, but more than the movement of the benchmark.
Bio-Techne Corp Thematic Clasifications
Bio Techne Corp is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
Bio-Techne Corp January 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bio-Techne Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bio Techne Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bio Techne Corp based on widely used predictive technical indicators. In general, we focus on analyzing Bio-Techne Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bio-Techne Corp's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.65 | |||
| Information Ratio | 0.0157 | |||
| Maximum Drawdown | 10.44 | |||
| Value At Risk | (4.23) | |||
| Potential Upside | 3.62 |
Additional Tools for Bio-Techne Stock Analysis
When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.